Purpose of dexa scan in osteoporosis patient

Reading File

Finding Sources

Searching PubMed

"DEXA" AND "osteoporosis" AND "bone mineral density"

Finding Sources

Reading File

Here is a thorough, textbook-grounded answer on the purpose of DEXA scan in osteoporosis:

Purpose of DEXA Scan in Osteoporosis

What is DEXA?

Dual-Energy X-ray Absorptiometry (DEXA or DXA) is the gold standard tool for assessing bone mineral density (BMD). During the procedure, two beams of different energy are directed at the patient, and the difference in absorption rates is recorded to quantify bone mineral content. It is fast, precise, and involves minimal radiation exposure.

Core Purposes

1. Diagnosis of Osteoporosis

DEXA generates a T-score - the standard deviation (SD) of the patient's BMD compared to a young, healthy reference population matched for gender and ethnicity. The WHO uses T-scores to classify bone health:

Category	T-score
Normal	≥ -1
Osteopenia	Between -1 and -2.5
Osteoporosis	≤ -2.5

Even with a normal or osteopenic T-score, the presence of one or more low-impact fragility fractures is considered severe osteoporosis.

Grainger & Allison's Diagnostic Radiology, p. 1085

2. Fracture Risk Prediction

DEXA BMD at specific sites predicts fracture risk. Total hip BMD is the single best predictor of future hip fracture. Central DEXA has better correlation with fracture risk than QCT scan BMD. - Swanson's Family Medicine Review, p. 372

3. Screening Indications

Per National Osteoporosis Foundation (NOF) guidelines, DEXA screening is indicated for:

All women aged 65 years or older
Younger postmenopausal women with one or more risk factors (using FRAX tool)
Patients with evidence of osteopenia on plain X-ray
At-risk individuals (rescreened every 4 years if initial testing is normal)

4. Monitoring Treatment Response

DEXA is used serially to assess whether pharmacologic treatment (bisphosphonates, teriparatide, etc.) is improving or stabilizing BMD over time. Peripheral BMD devices lack the precision of central DEXA and should NOT be used for this purpose.

5. Guiding Treatment Decisions

DEXA T-scores directly guide when to start pharmacotherapy:

T-score below -2.0 - treat
T-score below -1.5 with one or more risk factors - treat
Established osteoporotic fracture - treat regardless of score

Measurement Sites

Central DEXA measures BMD at:

Lumbar spine (L1-L4)
Femoral neck
Total proximal femur (hip)

At least two sites (preferably spine + hip) should always be measured. Ward's triangle (a computer-generated low-density area in the femoral head) should not be used for diagnosis.

Why Not Other Tests?

Modality	Limitation
Plain X-ray	Only detects advanced bone loss (>30% BMD lost); not suitable for screening
QCT	Cannot assess proximal femur; higher radiation; inferior fracture correlation
Peripheral DEXA / QUS	Lack precision for diagnosis or monitoring; not standardized

Important Note on Z-scores

The WHO osteopenia/osteoporosis definition using T-scores applies to postmenopausal women and men ≥50 years. For younger men, premenopausal women, and children, a Z-score (age-matched comparison) is used instead, and a Z-score ≤ -2 indicates "below expected range for age."

Summary

In osteoporosis, DEXA serves five key roles: diagnosis (T-score classification), fracture risk stratification, screening of at-risk populations, treatment decision-making, and monitoring therapeutic response. It remains the universally adopted standard because of its precision, low radiation, speed, and strong fracture predictive validity.

Swanson's Family Medicine Review, p. 372-376
Grainger & Allison's Diagnostic Radiology, p. 1083-1088

Recent evidence note: A 2026 systematic review (PMID: 41232350, J Clin Densitom) confirmed DEXA's superior diagnostic performance compared to other radiological modalities for osteoporosis detection, supporting its continued status as the reference standard.

This is a shared conversation. Sign in to Orris to start your own chat.